195 related articles for article (PubMed ID: 32893145)
21. A knowledge-based organ dose prediction tool for brachytherapy treatment planning of patients with cervical cancer.
Yusufaly TI; Kallis K; Simon A; Mayadev J; Yashar CM; Einck JP; Mell LK; Brown D; Scanderbeg D; Hild SJ; Covele B; Moore KL; Meyers SM
Brachytherapy; 2020; 19(5):624-634. PubMed ID: 32513446
[TBL] [Abstract][Full Text] [Related]
22. Developing Next-Generation 3-Dimensional Printing for Cervical Cancer Hybrid Brachytherapy: A Guided Interstitial Technique Enabling Improved Flexibility, Dosimetry, and Efficiency.
Marar M; Niedermayr T; Kidd EA
Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):312-320. PubMed ID: 37059235
[TBL] [Abstract][Full Text] [Related]
23. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: three-dimensional computed tomography plan evaluation.
Cengiz M; Gürdalli S; Selek U; Yildiz F; Saglam Y; Ozyar E; Atahan IL
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):464-8. PubMed ID: 17768014
[TBL] [Abstract][Full Text] [Related]
24. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results.
Beriwal S; Kannan N; Kim H; Houser C; Mogus R; Sukumvanich P; Olawaiye A; Richard S; Kelley JL; Edwards RP; Krivak TC
Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):685-90. PubMed ID: 21908180
[TBL] [Abstract][Full Text] [Related]
25. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
[TBL] [Abstract][Full Text] [Related]
26. A novel multi-modality imaging phantom for validating interstitial needle guidance for high dose rate gynecological brachytherapy.
Eckroate B; Ayala-Peacock D; Venkataraman R; Campelo S; Chino J; Stephens SJ; Kim Y; Meltsner S; Raffi J; Craciunescu O
J Appl Clin Med Phys; 2023 Oct; 24(10):e14075. PubMed ID: 37335537
[TBL] [Abstract][Full Text] [Related]
27. Computer tomography-assisted three-dimensional technique to assess rectal and bladder wall dose in intracavitary brachytherapy for uterine cervical cancer.
Sun LM; Huang EY; Ko SF; Wang CJ; Leung SW; Lin H; Wu JM; Wu IH; Lee SP
Radiother Oncol; 2004 Jun; 71(3):333-7. PubMed ID: 15172150
[TBL] [Abstract][Full Text] [Related]
28. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of an MR-only interstitial gynecologic brachytherapy workflow using MR-line marker for catheter reconstruction.
Shaaer A; Paudel M; Smith M; Tonolete F; Nicolae A; Leung E; Ravi A
Brachytherapy; 2020; 19(5):642-650. PubMed ID: 32712027
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of interfractional variation of organs and displacement of catheters during high-dose-rate interstitial brachytherapy for gynecologic malignancies.
Lee S; Rodney E; Traughber B; Biswas T; Colussi V; Podder T
Brachytherapy; 2017; 16(6):1192-1198. PubMed ID: 28993108
[TBL] [Abstract][Full Text] [Related]
31. Comparative evaluation of two-dimensional radiography and three dimensional computed tomography based dose-volume parameters for high-dose-rate intracavitary brachytherapy of cervical cancer: a prospective study.
Madan R; Pathy S; Subramani V; Sharma S; Mohanti BK; Chander S; Thulkar S; Kumar L; Dadhwal V
Asian Pac J Cancer Prev; 2014; 15(11):4717-21. PubMed ID: 24969909
[TBL] [Abstract][Full Text] [Related]
32. In vivo diode dosimetry vs. computerized tomography and digitally reconstructed radiographs for critical organ dose calculation in high-dose-rate brachytherapy of cervical cancer.
Hassouna AH; Bahadur YA; Constantinescu C; El Sayed ME; Naseem H; Naga AF
Brachytherapy; 2011; 10(6):498-502. PubMed ID: 21640661
[TBL] [Abstract][Full Text] [Related]
33. Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.
Harkenrider MM; Surucu M; Harmon G; Mysz ML; Shea SM; Yacoub J; Goldberg A; Liotta M; Winder A; Potkul R; Roeske JC; Small W
Brachytherapy; 2018; 17(1):187-193. PubMed ID: 29089277
[TBL] [Abstract][Full Text] [Related]
34. Applying 3D-Printed Templates in High-Dose-Rate Brachytherapy for Cervix Cancer: Simplified Needle Insertion for Optimized Dosimetry.
Marar M; Simiele E; Niedermayr T; Kidd EA
Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):111-119. PubMed ID: 35654306
[TBL] [Abstract][Full Text] [Related]
35. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
36. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
[TBL] [Abstract][Full Text] [Related]
37. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging.
Price MJ; Jackson EF; Gifford KA; Eifel PJ; Mourtada F
Med Phys; 2009 Dec; 36(12):5515-24. PubMed ID: 20095264
[TBL] [Abstract][Full Text] [Related]
38. Megavoltage computed tomography image-based low-dose rate intracavitary brachytherapy planning for cervical carcinoma.
Wagner TH; Langen KM; Meeks SL; Willoughby TR; Zeidan OA; Staton RJ; Shah AP; Manon RR; Kupelian PA
Technol Cancer Res Treat; 2009 Apr; 8(2):123-30. PubMed ID: 19334793
[TBL] [Abstract][Full Text] [Related]
39. Dose-volume histogram parameters of high-dose-rate brachytherapy for Stage I-II cervical cancer (≤4cm) arising from a small-sized uterus treated with a point A dose-reduced plan.
Nakagawa A; Ohno T; Noda SE; Kubo N; Kuwako K; Saitoh J; Nakano T
J Radiat Res; 2014 Jul; 55(4):788-93. PubMed ID: 24566721
[TBL] [Abstract][Full Text] [Related]
40. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
